FDA called out for its slow approval of already approved by the EU monkeypox vaccine

There’s an increasing demand for the monkeypox vaccine here in the United States, but people will have to wait because the FDA literally just got around to inspecting the factory in Denmark that manufactured the vaccine and it’s not yet cleared for distribution:

FDA officials took months to inspect a critical pharmaceutical plant in Europe, leaving Americans without shots as monkeypox spreads. @MrJDWalsh reports https://t.co/wEQJg7ZFAg

— New York Magazine (@NYMag) July 8, 2022